{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:36:48Z","timestamp":1762522608301,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.parint.2021.102417","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T23:49:00Z","timestamp":1625269740000},"page":"102417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?"],"prefix":"10.1016","volume":"85","author":[{"given":"Giorgia","family":"Montrucchio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Pomero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Perotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Fanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Brazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2021.102417_bb0005","doi-asserted-by":"crossref","first-page":"102241","DOI":"10.1016\/j.parint.2020.102241","article-title":"Giardiasis reactivation during severe SARS-CoV-2 infection","volume":"80","author":"Lupia","year":"2021","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.parint.2021.102417_bb0010","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy161","article-title":"A review of the global burden, new diagnostics, and current therapeutics for amebiasis","volume":"5","author":"Shirley","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.parint.2021.102417_bb0015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4321\/S1130-01082010000200004","article-title":"Pyogenic versus amoebic liver abscesses. A comparative clinical study of 58 patients","volume":"102","author":"Cosme","year":"2010","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.parint.2021.102417_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00279-19","article-title":"Entamoeba histolytica interaction with enteropathogenic Escherichia coli increases parasite virulence and inflammation in amebiasis","volume":"87","author":"Fern\u00e1ndez-L\u00f3pez","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parint.2021.102417_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00540-19","article-title":"Functional characterization of an interferon gamma receptor-like protein on Entamoeba histolytica","volume":"87","author":"Pulido-Ortega","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parint.2021.102417_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585647","article-title":"Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients","author":"Hu","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.parint.2021.102417_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13099-021-00427-3","article-title":"Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections","volume":"13","author":"Abdel-Hamed","year":"2021","journal-title":"Gut Pathog."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576921001355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576921001355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:33:46Z","timestamp":1761302026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576921001355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":7,"alternative-id":["S1383576921001355"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2021.102417","relation":{},"ISSN":["1383-5769"],"issn-type":[{"type":"print","value":"1383-5769"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 infection and parasitic diseases: A possible role for microbiome interaction?","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2021.102417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102417"}}